Question

If you are a Director R&D Clinical Studies

Please answer the following questions No Plagiarism please

Try to use approximately 100 words each question

Please type

Please do no plagiarize. If you don't know don't answer.

12.       How has your work with clinical trials management changed over the 10 years you have been  with this company?

13.       How would you say that your job relates to the drug development process?

14.       What has been the most difficult part of working with clinical trials?

15       Have you had to handle many adverse events and serious adverse events?

16.       If you could change anything about clinical trials and drug development, what would it be?

17.       What do you foresee for the future of the path clinical trials and drug development are taking?

18.       Have you been involved in clinical trial audits? What would you suggest to a new clinical trials manager who is to undergo his or her first audit?

19.       What do you like most about your job?

20.       What do you like least?

Answer 1

12. Clinical trials are the form of medical research that involve experiment or observation in order to study new test or drug and involve in evaluating their effect on human health. The new drugs are the key value driver of every research based pharma company. Therefore an effective and effecient measures have to be taken for the successful approval and launching the new drug in market. As a director R&D studies, clinical trials process has changed over the past 10years so to attain maximum benefit taken into consideration the health benefits to population also. The key factor and the success factor determine the R&D output is to increase the efficiency and various steps has been taken forward to attain this goal like reduce project portfolio activities and project risk, outsourcing & sharing risk in the later stage of development, activities to reduce the R&D cost and increase the innovation potential. Another key to success in tghis sector is the cumulative R&D expenditure, not only as whole but as well as individual companies. Measures has been taken to put forward the different ideas in R&D investment.  The company will keep on identifying the right growth strategies required to build up the right core competences for drug R&D internally.